Clinical Trials for IMUNON

Explore 3 clinical trials worldwide

Showing 1-3 of 3 trials

Active filters:Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruitingSponsor: IMUNON

Clinical Trials (3)

NCT06915025
Phase 3 Trial Evaluating the Safety & Efficacy of IMNN-001 Administered in Combination w/ Standard NACT & Adjuvant Chemotherapy in Newly Diagnosed Patients w/ Advanced EOC, Fallopian Tube or Primary Peritoneal Cancer
PHASE3Recruiting
500 participants
Started: Jul 9, 2025 · Completed: Oct 31, 2032
4 conditions1 sponsor4 locations
NCT05739981
Phase II IMNN-001 (Also Known as GEN-1) on SLL With BEV and NACT, Newly Diagnosed Advanced Ovarian, Fallopian Tube or Primary Peritoneal Cancer
PHASE1/PHASE2Recruiting
50 participants
Started: Feb 10, 2023 · Completed: Jan 30, 2028
3 conditions2 sponsors4 locations
NCT03393884
Study of IMNN-001 (Also Known as GEN-1) With NACT for Treatment of Ovarian Cancer (OVATION 2)
PHASE1/PHASE2Active, not recruiting
130 participants
Started: Sep 5, 2018 · Completed: Nov 30, 2025
3 conditions1 sponsor21 locations